Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 60.44B | 62.50B | 51.42B | 58.39B | 51.73B | 41.96B |
Gross Profit | 26.62B | 26.34B | 22.34B | 27.19B | 24.39B | 19.00B |
EBITDA | 12.95B | 14.27B | 10.78B | 14.97B | 13.72B | 9.33B |
Net Income | 8.97B | 9.43B | 6.50B | 10.59B | 9.16B | 5.61B |
Balance Sheet | ||||||
Total Assets | 57.85B | 90.91B | 84.14B | 80.10B | 76.32B | 66.26B |
Cash, Cash Equivalents and Short-Term Investments | 25.35B | 27.86B | 34.93B | 36.24B | 36.56B | 31.32B |
Total Debt | 7.00M | 0.00 | 291.00M | 352.00M | 262.00M | 144.00M |
Total Liabilities | 7.62B | 14.01B | 11.57B | 11.09B | 13.35B | 10.17B |
Stockholders Equity | 50.23B | 76.12B | 72.58B | 69.01B | 62.97B | 56.09B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 413.00M | 3.71B | 5.62B | 7.68B | 7.46B |
Operating Cash Flow | 0.00 | 12.99B | 7.45B | 7.38B | 9.30B | 8.74B |
Investing Cash Flow | 0.00 | -15.87B | -5.31B | -822.00M | -1.10B | -42.00M |
Financing Cash Flow | 0.00 | -5.64B | -5.64B | -6.14B | -3.83B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥154.68B | 15.99 | 3.61% | 18.61% | 30.56% | ||
56 Neutral | $7.08B | 5.28 | -5.20% | 5.56% | 8.18% | -38.45% | |
$1.04B | 10.19 | 7.01% | 5.37% | ― | ― | ||
€854.21M | 17.08 | 13.50% | 1.03% | ― | ― | ||
69 Neutral | ¥203.07B | 4.00 | 0.38% | -48.30% | ― | ||
¥209.34B | 22.83 | 1.28% | ― | ― | |||
74 Outperform | ¥137.46B | 15.36 | 3.39% | 9.00% | -50.84% |
Fujimi Incorporated reported significant growth in their financial performance for the nine months ending December 31, 2024, with a 23.9% increase in net sales and a substantial rise in operating profit by 48.3%. This financial improvement reflects positively on their market position, indicating a robust recovery from the previous period’s declines and a promising outlook for stakeholders.